Cargando…

A clinico-ethical framework for multidisciplinary review of medication in nursing homes

Residents in care homes are more likely to be prescribed multiple medicines yet often have little involvement in these prescribing decisions. Reviewing and stopping inappropriate medicines is not currently adopted across the health economy. This Health Foundation funded Shine project developed a pra...

Descripción completa

Detalles Bibliográficos
Autores principales: Baqir, Wasim, Barrett, Steven, Desai, Nisha, Copeland, Richard, Hughes, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645934/
https://www.ncbi.nlm.nih.gov/pubmed/26734305
http://dx.doi.org/10.1136/bmjquality.u203261.w2538
_version_ 1782400897822752768
author Baqir, Wasim
Barrett, Steven
Desai, Nisha
Copeland, Richard
Hughes, Julian
author_facet Baqir, Wasim
Barrett, Steven
Desai, Nisha
Copeland, Richard
Hughes, Julian
author_sort Baqir, Wasim
collection PubMed
description Residents in care homes are more likely to be prescribed multiple medicines yet often have little involvement in these prescribing decisions. Reviewing and stopping inappropriate medicines is not currently adopted across the health economy. This Health Foundation funded Shine project developed a pragmatic approach to optimising medicines in care homes while involving all residents in decision making. The pharmacist undertook a detailed medication review using primary care records. The results were discussed at a multidisciplinary team (MDT) meeting involving the care home nurse and the resident's general practitioner (GP), with input from the local psychiatry of old age service (POAS) where appropriate. Suggestions for medicines which should be stopped, changed or started, and other interventions (eg monitoring) were discussed with the resident and/or their family. Over 12 months 422 residents were reviewed, and 1346 interventions were made in 91% of residents reviewed with 15 different types of interventions. The most common intervention (52.3%) was to stop medicines; 704 medicines stopped in 298 residents (70.6%). On average, 1.7 medicines were stopped for every resident reviewed (range zero to nine medicines; SD=1.7), with a 17.4% reduction in medicines prescribed (3602 medicines prescribed before and 2975 after review). The main reasons for stopping medicines were: no current indication (401 medicines; 57%), resident not wanting medicine after risks and benefits were explained (120 medicines; 17%), and safety concerns (42 medicines; 6%). The net annualised savings against the medicines budget were £77,703 or £184 per person reviewed. The cost of delivering the intervention was £32,670 (pharmacist, GP, POAS consultant, and care home nurse time) for 422 residents; for every £1 invested, £2.38 could be released from the medicines budget. This project demonstrated that a multidisciplinary medication review with a pharmacist, doctor, and care home nurse can safely reduce inappropriate medication in elderly care home residents.
format Online
Article
Text
id pubmed-4645934
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher British Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46459342016-01-05 A clinico-ethical framework for multidisciplinary review of medication in nursing homes Baqir, Wasim Barrett, Steven Desai, Nisha Copeland, Richard Hughes, Julian BMJ Qual Improv Rep BMJ Quality Improvement Programme Residents in care homes are more likely to be prescribed multiple medicines yet often have little involvement in these prescribing decisions. Reviewing and stopping inappropriate medicines is not currently adopted across the health economy. This Health Foundation funded Shine project developed a pragmatic approach to optimising medicines in care homes while involving all residents in decision making. The pharmacist undertook a detailed medication review using primary care records. The results were discussed at a multidisciplinary team (MDT) meeting involving the care home nurse and the resident's general practitioner (GP), with input from the local psychiatry of old age service (POAS) where appropriate. Suggestions for medicines which should be stopped, changed or started, and other interventions (eg monitoring) were discussed with the resident and/or their family. Over 12 months 422 residents were reviewed, and 1346 interventions were made in 91% of residents reviewed with 15 different types of interventions. The most common intervention (52.3%) was to stop medicines; 704 medicines stopped in 298 residents (70.6%). On average, 1.7 medicines were stopped for every resident reviewed (range zero to nine medicines; SD=1.7), with a 17.4% reduction in medicines prescribed (3602 medicines prescribed before and 2975 after review). The main reasons for stopping medicines were: no current indication (401 medicines; 57%), resident not wanting medicine after risks and benefits were explained (120 medicines; 17%), and safety concerns (42 medicines; 6%). The net annualised savings against the medicines budget were £77,703 or £184 per person reviewed. The cost of delivering the intervention was £32,670 (pharmacist, GP, POAS consultant, and care home nurse time) for 422 residents; for every £1 invested, £2.38 could be released from the medicines budget. This project demonstrated that a multidisciplinary medication review with a pharmacist, doctor, and care home nurse can safely reduce inappropriate medication in elderly care home residents. British Publishing Group 2014-12-10 /pmc/articles/PMC4645934/ /pubmed/26734305 http://dx.doi.org/10.1136/bmjquality.u203261.w2538 Text en © 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/http://creativecommons.org/licenses/by-nc/2.0/legalcode
spellingShingle BMJ Quality Improvement Programme
Baqir, Wasim
Barrett, Steven
Desai, Nisha
Copeland, Richard
Hughes, Julian
A clinico-ethical framework for multidisciplinary review of medication in nursing homes
title A clinico-ethical framework for multidisciplinary review of medication in nursing homes
title_full A clinico-ethical framework for multidisciplinary review of medication in nursing homes
title_fullStr A clinico-ethical framework for multidisciplinary review of medication in nursing homes
title_full_unstemmed A clinico-ethical framework for multidisciplinary review of medication in nursing homes
title_short A clinico-ethical framework for multidisciplinary review of medication in nursing homes
title_sort clinico-ethical framework for multidisciplinary review of medication in nursing homes
topic BMJ Quality Improvement Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645934/
https://www.ncbi.nlm.nih.gov/pubmed/26734305
http://dx.doi.org/10.1136/bmjquality.u203261.w2538
work_keys_str_mv AT baqirwasim aclinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes
AT barrettsteven aclinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes
AT desainisha aclinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes
AT copelandrichard aclinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes
AT hughesjulian aclinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes
AT baqirwasim clinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes
AT barrettsteven clinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes
AT desainisha clinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes
AT copelandrichard clinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes
AT hughesjulian clinicoethicalframeworkformultidisciplinaryreviewofmedicationinnursinghomes